These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
26. [Effect of Epitalon and Vilon treatment on mammary carcinogenesis in transgenic erbB-2/NEU mice]. Alimova IN; Bashurin DA; Popovich IG; Zabezhinskiĭ MA; Volkov MA; Provinciali M; Franceschi C; Khavincon BKh; Anisimov VN Vopr Onkol; 2002; 48(1):57-60. PubMed ID: 12101568 [TBL] [Abstract][Full Text] [Related]
27. Low-thiamine diet increases mammary tumor latency in FVB/N-Tg(MMTVneu) mice. Daily A; Liu S; Bhatnagar S; Karabakhtsian RG; Moscow JA Int J Vitam Nutr Res; 2012 Aug; 82(4):298-302. PubMed ID: 23591667 [TBL] [Abstract][Full Text] [Related]
28. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice. Cool M; Jolicoeur P Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755 [TBL] [Abstract][Full Text] [Related]
29. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107 [TBL] [Abstract][Full Text] [Related]
30. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Kim J; Siverly AN; Chen D; Wang M; Yuan Y; Wang Y; Lee H; Zhang J; Muller WJ; Liang H; Gan B; Yang X; Sun Y; You MJ; Ma L Cancer Res; 2016 Nov; 76(21):6424-6435. PubMed ID: 27569213 [TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
33. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells. Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670 [TBL] [Abstract][Full Text] [Related]
34. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944 [TBL] [Abstract][Full Text] [Related]
35. Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains. Danciger M; Yang H; Ralston R; Liu Y; Matthes MT; Peirce J; Lavail MM Mol Vis; 2007 Jan; 13():79-85. PubMed ID: 17277741 [TBL] [Abstract][Full Text] [Related]
36. Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis. Gordon RR; La Merrill M; Hunter KW; Sørensen P; Threadgill DW; Pomp D Clin Exp Metastasis; 2010 May; 27(5):279-93. PubMed ID: 20354763 [TBL] [Abstract][Full Text] [Related]
37. Sasa health exerts a protective effect on Her2/NeuN mammary tumorigenesis. Ren M; Reilly RT; Sacchi N Anticancer Res; 2004; 24(5A):2879-84. PubMed ID: 15517891 [TBL] [Abstract][Full Text] [Related]